Tet systems—Tet-On 3G
Compared to their predecessors (Tet-On and Tet-On Advanced systems), Tet-On 3G systems demonstrate lower basal expression (by 5- to 20-fold) and higher sensitivity to doxycycline (Dox) induction, which is particularly advantageous for in vivo studies in tissues where high Dox concentrations are difficult to attain (e.g., brain). We offer several plasmid and viral delivery options for the Tet-On 3G system, plus promoters that allow for consistent long-term expression of the Tet transactivator.
Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2020 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.